Evidence map›Paper›PMID 29692905›Full record

ArticleNew microbes and new infections2018

S Ndongo, F Bittar, M Beye, C Robert, F Di Pinto, P-E Fournier, D Raoult, J-C Lagier

RetractedAbstract read
In one paragraph

Article in New microbes and new infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Characterization ofFrontiers in cellular and infection microbiology · 2022
    Article
  5. New microbes and new infections · 2020
    Article
  6. New microbes and new infections · 2019
    Article
  7. New microbes and new infections · 2019
    Article
  8. Genome sequence and description ofNew microbes and new infections · 2019
    Article
  9. New microbes and new infections · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

S NdongoAix-Marseille Université, IRD, AP-HM, IHU-Méditerranée Infection, UMR Microbes Evolution Phylogénie (MEPHI), Marseille, France.
F BittarAix Marseille Univ, IRD (Dakar, Marseille, Papeete), AP-HM, IHU-Méditerranée Infection, UMR Vecteurs - Infections Tropicales et Méditerranéennes (VITROME), Marseille, France.
M BeyeAix Marseille Univ, IRD (Dakar, Marseille, Papeete), AP-HM, IHU-Méditerranée Infection, UMR Vecteurs - Infections Tropicales et Méditerranéennes (VITROME), Marseille, France.
C RobertAix-Marseille Université, IRD, AP-HM, IHU-Méditerranée Infection, UMR Microbes Evolution Phylogénie (MEPHI), Marseille, France.
F Di PintoAix-Marseille Université, IRD, AP-HM, IHU-Méditerranée Infection, UMR Microbes Evolution Phylogénie (MEPHI), Marseille, France.
P-E FournierAix Marseille Univ, IRD (Dakar, Marseille, Papeete), AP-HM, IHU-Méditerranée Infection, UMR Vecteurs - Infections Tropicales et Méditerranéennes (VITROME), Marseille, France.
D RaoultAix-Marseille Université, IRD, AP-HM, IHU-Méditerranée Infection, UMR Microbes Evolution Phylogénie (MEPHI), Marseille, France.
J-C LagierAix-Marseille Université, IRD, AP-HM, IHU-Méditerranée Infection, UMR Microbes Evolution Phylogénie (MEPHI), Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cellulomonas timonensisculturomicsgenomehuman gut microbiotataxonogenomics

Identifiers

PMID29692905
PMCPMC5913061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.